Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and responseOk-Kyong Chaekal, Koen van Besien, Sang‐Min Lee et al.|Blood Advances|2020Cited by 5
Effect of Cord Blood Vs Adult Stem Cell Sources on Outcome of Patients with Mutated TP53 Hematologic MalignanciesAlexandra Gomez-Arteaga, Koen van Besien, Jingmei Hsu et al.|Transplantation and Cellular Therapy|2021Cited by 0
Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell TransplantMateo Mejía Saldarriaga, Jingmei Hsu, Yassine Tahri et al.|Blood|2021Cited by 0
Impact of Peri-Transplant Molecular Mutations Onoutcomes of AML Patients Undergoing Fludarabine/ Melphalan Conditioned Allogeneic Stem Cell TransplantMateo Mejía Saldarriaga, Jingmei Hsu, Yassine Tahri et al.|Transplantation and Cellular Therapy|2022Cited by 0
Outcomes of Cord Blood Vs Adult Stem Cell Sources in Patients with Mutated TP53 Myeloid MalignanciesNora Chokr, Alexandra Gomez-Arteaga, Joshua Fein et al.|Transplantation and Cellular Therapy|2023Cited by 0